Short Interest in Intelligent Bio Solutions Inc. (NASDAQ:INBS) Declines By 5.1%

Intelligent Bio Solutions Inc. (NASDAQ:INBS) saw a large decrease in short interest during the month of December. As of December 31st, there was short interest totalling 427,400 shares, a decrease of 5.1% from the December 15th total of 450,500 shares. Based on an average daily volume of 118,600 shares, the days-to-cover ratio is currently 3.6 days. Approximately 9.1% of the company’s stock are sold short.

Intelligent Bio Solutions Price Performance

Intelligent Bio Solutions stock opened at $1.39 on Tuesday. Intelligent Bio Solutions has a one year low of $1.00 and a one year high of $11.70. The company’s fifty day moving average price is $1.48 and its two-hundred day moving average price is $1.52.

Intelligent Bio Solutions (NASDAQ:INBS) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.70) EPS for the quarter, missing analysts’ consensus estimates of ($0.53) by ($0.17). Intelligent Bio Solutions had a negative net margin of 288.35% and a negative return on equity of 147.50%. The company had revenue of $872.29 million for the quarter. Sell-side analysts anticipate that Intelligent Bio Solutions will post -1.25 EPS for the current year.

Intelligent Bio Solutions Company Profile

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.